4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0000950170-24-084952
Options or other derivatives
- EVP, COO acquired 12,825 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lamothe Jeffrey G. EVP, COO | 2024-07-17 | Grant or award · Restricted Stock Unit | +12,825 | 12,825 | D | ||
Loading xslF345X05/ownership.xml…